Healthcare provider profile · identity verified

Richard R Sampson, MD

Family Practice · BARRON, WI · NPI 1104882604

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	501	143
Levothyroxine Sodium	Levothyroxine Sodium	433	98
Lisinopril	Lisinopril	361	99
Amlodipine Besylate	Amlodipine Besylate	353	88
Omeprazole	Omeprazole	325	85
Furosemide	Furosemide	323	67
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	270	35
Warfarin Sodium	Warfarin Sodium	256	37
Potassium Chloride	Potassium Chloride	222	57
Gabapentin	Gabapentin	221	61
Hydrochlorothiazide	Hydrochlorothiazide	201	51
Sertraline Hcl	Sertraline Hcl	196	37
Metformin Hcl	Metformin Hcl	192	62
Metoprolol Tartrate	Metoprolol Tartrate	184	53
Losartan Potassium	Losartan Potassium	181	49
Tramadol Hcl	Tramadol Hcl	181	35
Metoprolol Succinate	Metoprolol Succinate	175	57
Tamsulosin Hcl	Tamsulosin Hcl	164	42
Simvastatin	Simvastatin	151	45
Morphine Sulfate Er	Morphine Sulfate	138	12
Eliquis	Apixaban	131	40
Pantoprazole Sodium	Pantoprazole Sodium	131	35
Allopurinol	Allopurinol	120	35
Rosuvastatin Calcium	Rosuvastatin Calcium	119	31
Metformin Hcl Er	Metformin Hcl	112	34
Albuterol Sulfate Hfa	Albuterol Sulfate	106	40
Pravastatin Sodium	Pravastatin Sodium	103	29
Alprazolam	Alprazolam	99	15
Duloxetine Hcl	Duloxetine Hcl	87	17
Glipizide	Glipizide	85	22
Clopidogrel	Clopidogrel Bisulfate	84	24
Atenolol	Atenolol	82	27
Fluticasone Propionate	Fluticasone Propionate	82	31
Glipizide Er	Glipizide	80	25
Pregabalin	Pregabalin	78	suppressed
Carvedilol	Carvedilol	75	20
Bupropion Xl	Bupropion Hcl	70	16
Oxycodone Hcl	Oxycodone Hcl	70	19
Famotidine	Famotidine	69	20
Fluoxetine Hcl	Fluoxetine Hcl	67	17
Jardiance	Empagliflozin	65	16
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	65	14
Ventolin Hfa	Albuterol Sulfate	65	22
Trazodone Hcl	Trazodone Hcl	63	20
Isosorbide Mononitrate Er	Isosorbide Mononitrate	61	16
Prednisone	Prednisone	60	24
Ezetimibe	Ezetimibe	59	14
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	58	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	58	15
Mirtazapine	Mirtazapine	56	13
Venlafaxine Hcl Er	Venlafaxine Hcl	55	suppressed
Diclofenac Sodium	Diclofenac Sodium	52	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	49	16
Oxybutynin Chloride Er	Oxybutynin Chloride	48	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	44	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	42	12
Clonazepam	Clonazepam	41	suppressed
Ropinirole Hcl	Ropinirole Hcl	41	suppressed
Nitroglycerin	Nitroglycerin	40	19
Citalopram Hbr	Citalopram Hydrobromide	39	suppressed
Incruse Ellipta	Umeclidinium Bromide	38	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	38	suppressed
Lorazepam	Lorazepam	37	13
Quetiapine Fumarate	Quetiapine Fumarate	36	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	35	suppressed
Semglee (Yfgn) Pen	Insulin Glargine-Yfgn	35	suppressed
Risperidone	Risperidone	33	suppressed
Torsemide	Torsemide	32	16
Amoxicillin	Amoxicillin	31	21
Buspirone Hcl	Buspirone Hcl	31	suppressed
Ketoconazole	Ketoconazole	31	13
Levetiracetam	Levetiracetam	31	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	30	suppressed
Methadone Hcl	Methadone Hcl	29	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	18
Estradiol	Estradiol	28	suppressed
Humalog Kwikpen U-100	Insulin Lispro	28	suppressed
Spironolactone	Spironolactone	28	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	27	suppressed
Celecoxib	Celecoxib	27	suppressed
Finasteride	Finasteride	27	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Novolog Flexpen	Insulin Aspart	27	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Tizanidine Hcl	Tizanidine Hcl	25	suppressed
Alendronate Sodium	Alendronate Sodium	24	suppressed
Meloxicam	Meloxicam	24	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	24	suppressed
Phenobarbital	Phenobarbital	24	suppressed
Diazepam	Diazepam	23	suppressed
Lansoprazole	Lansoprazole	23	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Breo Ellipta	Fluticasone/Vilanterol	21	suppressed
Nystatin	Nystatin	21	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	21	suppressed
Azithromycin	Azithromycin	20	16
Loperamide	Loperamide Hcl	20	suppressed
Verapamil Er	Verapamil Hcl	20	suppressed
Latanoprost	Latanoprost	19	suppressed
Niacin Er	Niacin	19	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	13
Fiasp Flextouch	Insulin Aspart (Niacinamide)	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Naproxen	Naproxen	17	suppressed
Chlorthalidone	Chlorthalidone	16	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	16	suppressed
Prazosin Hcl	Prazosin Hcl	16	suppressed
Valacyclovir	Valacyclovir Hcl	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Methocarbamol	Methocarbamol	15	suppressed
Nadolol	Nadolol	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Ondansetron Odt	Ondansetron	14	suppressed
Ozempic	Semaglutide	14	suppressed
Ramipril	Ramipril	14	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	14	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	13	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	13	suppressed
Azurette	Desog-E.Estradiol/E.Estradiol	13	suppressed
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	13	suppressed
Primidone	Primidone	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	13	suppressed
Bumetanide	Bumetanide	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Levofloxacin	Levofloxacin	12	suppressed
Mounjaro	Tirzepatide	12	suppressed
Valsartan	Valsartan	12	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	11	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	11	suppressed
Klor-Con M20	Potassium Chloride	11	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	11	suppressed
Ursodiol	Ursodiol	11	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error